Vázquez-Mellado J - Search Results

1

Severe tophaceous gout. Characterization of low socioeconomic level patients from México.

Vázquez-Mellado J, Cruz J, Guzmán S, Casasola-Vargas J, Lino L, Burgos-Vargas R. Vázquez-Mellado J, et al. Clin Exp Rheumatol. 2006 May-Jun;24(3):233-8. Clin Exp Rheumatol. 2006. PMID: 16870088

2

Immunoregulatory defects in juvenile rheumatoid arthritis. Comparison between patients with the systemic or polyarticular forms.

Alarcon-Riquelme ME, Vazquez-Mellado J, Gomez-Cordillo M, Alcocer-Varela J, Burgos-Vargas R, Alarcón-Segovia D. Alarcon-Riquelme ME, et al. J Rheumatol. 1988 Oct;15(10):1547-50. J Rheumatol. 1988. PMID: 2974488

3

Genuine ankylosing spondylitis in children: a case-control study of patients with early definite disease according to adult onset criteria.

Burgos-Vargas R, Vázquez-Mellado J, Cassis N, Duarte C, Casarín J, Cifuentes M, Lino L. Burgos-Vargas R, et al. J Rheumatol. 1996 Dec;23(12):2140-7. J Rheumatol. 1996. PMID: 8970053

4

Intradermal tophi in gout: a case-control study.

Vázquez-Mellado J, Cuan A, Magaña M, Pineda C, Cazarín J, Pacheco-Tena C, Burgos-Vargas R. Vázquez-Mellado J, et al. J Rheumatol. 1999 Jan;26(1):136-40. J Rheumatol. 1999. PMID: 9918254

5

A proposal for the classification of patients for clinical and experimental studies on reactive arthritis.

Pacheco-Tena C, Burgos-Vargas R, Vázquez-Mellado J, Cazarín J, Pérez-Díaz JA. Pacheco-Tena C, et al. J Rheumatol. 1999 Jun;26(6):1338-46. J Rheumatol. 1999. PMID: 10381053

6

Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.

Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R. Luis M, et al. Arthritis Rheum. 1999 Oct;42(10):2160-5. doi: 10.1002/1529-0131(199910)42:10<2160::AID-ANR17>3.0.CO;2-T. Arthritis Rheum. 1999. PMID: 10524688 Clinical Trial.

7

Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies.

Pacheco-Tena C, Alvarado De La Barrera C, López-Vidal Y, Vázquez-Mellado J, Richaud-Patin Y, Amieva RI, Llorente L, Martínez A, Zúñiga J, Cifuentes-Alvarado M, Burgos-Vargas R. Pacheco-Tena C, et al. Rheumatology (Oxford). 2001 Aug;40(8):920-7. doi: 10.1093/rheumatology/40.8.920. Rheumatology (Oxford). 2001. PMID: 11511762

8

Relation between adverse events associated with allopurinol and renal function in patients with gout.

Vázquez-Mellado J, Morales EM, Pacheco-Tena C, Burgos-Vargas R. Vázquez-Mellado J, et al. Ann Rheum Dis. 2001 Oct;60(10):981-3. doi: 10.1136/ard.60.10.981. Ann Rheum Dis. 2001. PMID: 11557658 Free PMC article.

9

The juvenile-onset spondyloarthritides: rationale for clinical evaluation.

Burgos-Vargas R, Pacheco-Tena C, Vázquez-Mellado J. Burgos-Vargas R, et al. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):551-72. doi: 10.1053/berh.2002.0247. Best Pract Res Clin Rheumatol. 2002. PMID: 12406427 Review.

10

A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies.

Burgos-Vargas R, Pacheco-Tena C, Vázquez-Mellado J. Burgos-Vargas R, et al. Clin Exp Rheumatol. 2002 Sep-Oct;20(5):727-31. Clin Exp Rheumatol. 2002. PMID: 12412210 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results